Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A NIXON

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Evolution & Development|November 16, 2023
Got milkweed? Genetic assimilation as potential source for the evolution of nonmigratory monarch butterfly wing shapeKyra J A Nixon, Harald F Parzer
The Journal of Cardiovascular Surgery|February 1, 1994
Management of a post-traumatic tracheo-esophageal fistula following failed primary repairR A Semlacher, B B Bharadwaj, J A Nixon
Annals of Surgery|November 1, 1996
Cooperative hernia study. Pain in the postrepair patientJ Cunningham, W J Temple, P Mitchell, et al.
Biochemical and Biophysical Research Communications|April 30, 1991
Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance PN Rouissi, B D Gitter, D C Waters, et al.
Life Sciences|January 1, 1997
The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigsL A Phebus, K W Johnson, P W Stengel, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Expedited discovery of second generation NK-1 antagonists: identification of a nonbasic aryloxy substituentJ E Fritz, P A Hipskind, K L Lobb, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonistB D Gitter, R F Bruns, J J Howbert, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
LY303870, a centrally active neurokinin-1 antagonist with a long duration of actionS Iyengar, P A Hipskind, D R Gehlert, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Structure-activity relationships of a series of 1-substituted-4-methylbenzimidazole neuropeptide Y-1 receptor antagonistsD M Zimmerman, B E Cantrell, E C Smith, et al.
Journal of Medicinal Chemistry|February 2, 1996
3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonistsP A Hipskind, J J Howbert, R F Bruns, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Evolution & Development|November 16, 2023
Got milkweed? Genetic assimilation as potential source for the evolution of nonmigratory monarch butterfly wing shapeKyra J A Nixon, Harald F Parzer
The Journal of Cardiovascular Surgery|February 1, 1994
Management of a post-traumatic tracheo-esophageal fistula following failed primary repairR A Semlacher, B B Bharadwaj, J A Nixon
Annals of Surgery|November 1, 1996
Cooperative hernia study. Pain in the postrepair patientJ Cunningham, W J Temple, P Mitchell, et al.
Biochemical and Biophysical Research Communications|April 30, 1991
Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance PN Rouissi, B D Gitter, D C Waters, et al.
Life Sciences|January 1, 1997
The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigsL A Phebus, K W Johnson, P W Stengel, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2001
Expedited discovery of second generation NK-1 antagonists: identification of a nonbasic aryloxy substituentJ E Fritz, P A Hipskind, K L Lobb, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonistB D Gitter, R F Bruns, J J Howbert, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
LY303870, a centrally active neurokinin-1 antagonist with a long duration of actionS Iyengar, P A Hipskind, D R Gehlert, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Structure-activity relationships of a series of 1-substituted-4-methylbenzimidazole neuropeptide Y-1 receptor antagonistsD M Zimmerman, B E Cantrell, E C Smith, et al.
Journal of Medicinal Chemistry|February 2, 1996
3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonistsP A Hipskind, J J Howbert, R F Bruns, et al.
Pageof 1